Preeclampsia Diagnostics Market Market Trends

  • Report ID: 4412
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Preeclampsia Diagnostics Market Market Trends

Growth Drivers

  • Market Expansion in Emerging Economies – The preeclampsia diagnostics market is growing rapidly in emerging economies such as India and China. This is due to several factors such as rising incomes, increasing access to healthcare and increasing awareness about preeclampsia.  This factor is anticipated to drive the growth of the preeclampsia diagnostics market in the anticipated time period.
  • Development of Innovative Tests - The development of early diagnostic tests for preeclampsia will help reduce maternal and neonatal mortality. Awareness of pre-eclampsia has increased recently, mainly due to campaigns by patient advocacy groups and welfare associations. This remains an important factor providing profitable growth opportunities for innovative test development given the significant unmet need for diagnosing pre-eclampsia worldwide.

Challenges

  • Lack of Reimbursement - The lack of reimbursement will limit the market growth during the forecast period. Most health insurance policies do not cover reimbursement for preeclampsia tests. Lack of reimbursement policy and high cost pose barriers to adoption of preeclampsia testing. Some state and federal officials as well as health officials have publicly encouraged payers to review their insurance policies for Diagnostics for preeclampsia. However, the market still lacks reimbursement services for preeclampsia testing. Such factors limit the growth of the market. Therefore, these factors are expected to restrict the market growth of preeclampsia diagnostics market in the projected timeframe.
  • High Cost of Preeclampsia Diagnostics is Expected to Hamper the Market Growth in Upcoming Period.
  • Lack of Skilled Professionals is Estimated to Restrict the Market Expansion in Future Time.

Preeclampsia Diagnostics Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

3.2%

Base Year Market Size (2024)

USD 1.38 billion

Forecast Year Market Size (2037)

USD 2.08 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4412
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of preeclampsia diagnostics is evaluated at USD 1.42 billion.

Preeclampsia Diagnostics Market size was over USD 1.38 billion in 2024 and is anticipated to exceed USD 2.08 billion by the end of 2037, witnessing over 3.2% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of pre-termed births, increasing innovative tests development will drive the market growth.

North America industry is expected to hold largest revenue share of 35% by 2037, due to increasing focus on drug delivery services and vaccine discovery and development in the region.

The major players in the market are of Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., Thermo Fisher Inc., Biora Therapeutics Inc, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample